Single-Use Bioreactor Subchambers for Sterile Processing

The manufacturing system is divided into multiple independent single-use bioreactors, each capable of operating autonomously in its own sterile environment. This segmentation allows small-scale facilities to achieve the same sterile reliability as large-scale facilities by isolating each processing unit, eliminating the need for large centralized cleanrooms while maintaining product safety.

The patent employs disposable single-use bioreactors that are pre-sterilized and sealed. These single-use containers eliminate the need for expensive, complex sterilization infrastructure and large-scale cleanrooms, as each bioreactor maintains its own sterile environment independently. After use, the entire bioreactor is discarded, avoiding the need for costly cleaning and validation procedures associated with reusable large-scale equipment.

Multiple single-use bioreactors can be operated in parallel to achieve the required processing capacity. This modular approach allows facilities to scale productivity by simply adding more independent units rather than investing in expensive large-scale facilities, making the system cost-effective while maintaining adequate throughput for personalized medicine production.

The system allows dynamic configuration and scaling of bioreactor networks. Facilities can start with a small number of bioreactors and gradually add more units as demand increases, avoiding the need for large upfront investments in oversized facilities. This dynamic scalability ensures cost-effectiveness by matching processing capacity to actual production needs.